| # | Cited
nodes | Nodes / Authors | GCS | LCS |
| 1 | 4 | 98 2003 ONCOGENE 22(10):1580-1588
Agathanggelou A; Dallol A; Zochbauer-Muller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F
Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers | 0 | 0
|
| 2 | 1 | 15 2001 ONCOGENE 20(51):7573-7577
Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HPH; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours | 17 | 14
|
| 3 | 2 | 22 2002 ANALYTICAL BIOCHEMISTRY 309(2):301-310
Balog RP; de Souza YEP; Tang HM; DeMasellis GM; Gao B; Avila A; Gaban DJ; Mittelman D; Minna JD; Luebke KJ; Garner HR
Parallel assessment of CpG methylation by two-color hybridization with oligonucleotide arrays | 1 | 0
|
| 4 | 1 | 81 2002 ONCOGENE 21(45):6877-6883
Balsara BR; Testa JR
Chromosomal imbalances in human lung cancer | 0 | 0
|
| 5 | 1 | 11 2001 JOURNAL OF THE NATIONAL CANCER INSTITUTE 93(9):664-665
Baylin SB; Herman JG
Promoter hypermethylation - Can this change alone ever designate true tumor suppressor gene function? | 11 | 2
|
| 6 | 1 | 58 2002 JOURNAL OF BIOLOGICAL CHEMISTRY 277(31):28176-28181
Beaulieu N; Morin S; Chute IC; Robert MF; Nguyen H; MacLeod AR
An essential role for DNA methyltransferase DNMT3B in cancer cell survival | 1 | 0
|
| 7 | 5 | 56 2002 HUMAN MOLECULAR GENETICS 11(20):2489-2498
Bodmer D; van den Hurk W; van Groningen JJM; Eleveld MJ; Martens GJM; Weterman MAJ; van Kessel AG
Understanding familial and non-familial renal cell cancer | 0 | 0
|
| 8 | 2 | 57 2002 INTERNATIONAL JOURNAL OF CANCER 100(5):534-541
Braga E; Senchenko V; Bazov I; Loginov W; Liu J; Ermilova V; Kazubskaya T; Garkavtseva R; Mazurenko N; Kisseljov F; Lerman MI; Klein G; Kisselev L; Zabarovsky ER
Critical tumor-suppressor gene regions on chromosome 3p in major human epithelial malignancies: Allelotyping and quantitative real-time PCR | 2 | 1
|
| 9 | 1 | 64 2002 LUNG CANCER 38(1):S5-S8
Bunn PA
Molecular biology and early diagnosis in lung cancer | 0 | 0
|
| 10 | 0 | 12 2001 JOURNAL OF THE NATIONAL CANCER INSTITUTE 93(9):691-699
Burbee DG; Forgacs E; Zochbauer-Muller S; Shivakumar L; Fong K; Gao BN; Randle D; Kondo M; Virmani A; Bader S; Sekido Y; Latif F; Milchgrub S; Toyooka S; Gazdar AF; Lerman MI; Zabarovsky E; White M; Minna JD
Epigenetic inactivation of RASSF14 in lung and breast cancers and malignant phenotype suppression | 100 | 100
|
| 11 | 1 | 4 2001 CANCER RESEARCH 61(19):7034-7038
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma | 13 | 12
|
| 12 | 2 | 28 2002 CANCER BIOLOGY & THERAPY 1(2):105-112
Campbell AM; Campling BG; Algazy KM; El-Deiry WS
Clinical and molecular features of small cell lung cancer | 0 | 0
|
| 13 | 1 | 43 2002 CLINICAL CANCER RESEARCH 8(12):3741-3746
Chan EC; Lam SY; Tsang KW; Lam B; Ho JCM; Fu KH; Lam WK; Kwong YL
Aberrant promoter methylation in Chinese patients with non- small cell lung cancer: Patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage | 0 | 0
|
| 14 | 5 | 94 2003 INTERNATIONAL JOURNAL OF CANCER 104(5):611-616
Chan MWY; Chan LW; Tang NLS; Lo KW; Tong JHM; Chan AWH; Cheung HY; Wong WS; Chan PSF; Lai FMM; To KF
Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients | 0 | 0
|
| 15 | 2 | 53 2002 GENES CHROMOSOMES & CANCER 34(1):97-103
Cheng Y; Chakrabarti R; Garcia-Barcelo M; Ha TJ; Srivatsan ES; Stanbridge EJ; Lung ML
Mapping of nasopharyngeal carcinoma tumor-suppressive activity to a 1.8-megabase region of chromosome band 11q13 | 2 | 1
|
| 16 | 1 | 27 2002 CANCER AND METASTASIS REVIEWS 21(3-4):349-362
Cohen V; Khuri FR
Chemoprevention of lung cancer: Current status and future prospects | 0 | 0
|
| 17 | 3 | 71 2002 ONCOGENE 21(19):3020-3028
Dallol A; Forgacs E; Martinez A; Sekido Y; Walker R; Kishida T; Rabbitts P; Maher ER; Minna JD; Latif F
Tumour specific promoter region methylation of the human homologue of the Drosophilia Roundabout gene DUTT1 (ROBO1) in human cancers | 3 | 1
|
| 18 | 26 | 92 2003 HISTOLOGY AND HISTOPATHOLOGY 18(2):665-677
Dammann R; Schagdarsurengin U; Strunnikova M; Rastetter M; Seidel C; Liu L; Tommasi S; Pfeifer GP
Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis | 0 | 0
|
| 19 | 3 | 101 2003 PHARMACOLOGICAL REVIEWS 55(1):57-103
Danesi R; De Braud F; Fogli S; De Pas TM; Di Paolo A; Curigliano G; Del Tacca M
Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer | 0 | 0
|
| 20 | 1 | 20 2001 TRENDS IN GENETICS 17(10):569-573
Devilee P; Cleton-Jansen AM; Cornelisse CJ
Ever since Knudson | 12 | 0
|
| 21 | 2 | 36 2002 CANCER RESEARCH 62(15):4514-4518
Diaz R; Ahn D; Lopez-Barcons L; Malumbres M; de Castro IP; Lue J; Ferrer-Miralles N; Mangues R; Tsong J; Garcia R; Perez-Soler R; Pellicer A
The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene | 0 | 0
|
| 22 | 3 | 23 2002 ANNALS OF MEDICINE 34(6):451-469
Ding HF; Fisher DE
Induction of apoptosis in cancer: new therapeutic opportunities | 0 | 0
|
| 23 | 1 | 16 2001 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98(13):7504-7509
Dreijerink K; Braga E; Kuzmin I; Geil L; Duh FM; Angeloni D; Zbar B; Lerman MI; Stanbridge EJ; Minna JD; Protopopov A; Li JF; Kashuba V; Klein G; Zabarovsky ER
The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis | 35 | 25
|
| 24 | 1 | 10 2001 JOURNAL OF HUMAN GENETICS 46(10):583-589
Druck T; Podolski J; Byrski T; Wyrwicz L; Zajaczek S; Kata G; Borowka A; Lubinski J; Huebner K
The DIRC1 gene at chromosome 2q33 spans a familial RCC- associated t(2;3)(q33;q21) chromosome translocation | 4 | 1
|
| 25 | 3 | 79 2002 ONCOGENE 21(43):6694-6702
Ehrlich M; Jiang GC; Fiala E; Dome JS; Yu MC; Long TI; Youn B; Sohn OS; Widschwendter M; Tomlinson GE; Chintagumpala M; Champagne M; Parham D; Liang GN; Malik K; Laird PW
Hypomethylation and hypermethylation of DNA in Wilms tumors | 3 | 1
|
| 26 | 2 | 46 2002 CURRENT BIOLOGY 12(7):R259-R261
Feig LA; Buchsbaum RJ
Cell signaling: Life or death decisions of Ras proteins | 1 | 1
|
| 27 | 1 | 44 2002 CLINICS IN CHEST MEDICINE 23(1):83-+
Fong KM; Minna JD
Molecular biology of lung cancer: Clinical implications | 1 | 0
|
| 28 | 3 | 33 2002 CANCER RESEARCH 62(12):3340-3346
Fujii T; Dracheva T; Player A; Chacko S; Clifford R; Strausberg RL; Buetow K; Azumi N; Travis WD; Jen J
A preliminary transcriptome map of non-small cell lung cancer | 3 | 0
|
| 29 | 1 | 60 2002 JOURNAL OF CLINICAL ONCOLOGY 20(2):588-598
Goessling W; McKee PH; Mayer RJ
Merkel cell carcinoma | 0 | 0
|
| 30 | 7 | 75 2002 ONCOGENE 21(27):4345-4349
Harada K; Toyooka S; Maitra A; Maruyama R; Toyooka KO; Timmons CF; Tomlinson GE; Mastrangelo D; Hay RJ; Minna JD; Gazdar AF
Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines | 4 | 3
|
| 31 | 3 | 37 2002 CANCER RESEARCH 62(20):5897-5901
Harada K; Toyooka S; Shivapurkar N; Maitra A; Reddy JL; Matta H; Miyajima K; Timmons CF; Tomlinson GE; Mastrangelo D; Hay RJ; Chaudhary PM; Gazdar AF
Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines | 1 | 0
|
| 32 | 2 | 73 2002 ONCOGENE 21(27):4231-4236
Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
Patterns of gene promoter methylation in squamous cell cancer of the head and neck | 3 | 1
|
| 33 | 10 | 97 2003 ONCOGENE 22(6):947-954
Hesson L; Dallol A; Minna JD; Maher ER; Latif F
NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers | 0 | 0
|
| 34 | 1 | 65 2002 LUNG CANCER 38():S81-S85
Hirsch FR; Fischer JR; Niklinski J; Zochbauer-Muller S
Future developments in the treatment of lung cancer | 0 | 0
|
| 35 | 1 | 51 2002 EUROPEAN RESPIRATORY JOURNAL 19(6):1151-1158
Hirsch FR; Merrick DT; Franklin WA
Role of biomarkers for early detection of lung cancer and chemoprevention | 0 | 0
|
| 36 | 1 | 50 2002 EUROPEAN JOURNAL OF CANCER 38(12):1585-1592
Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma | 1 | 1
|
| 37 | 7 | 95 2003 ONCOGENE 22(1):147-150
Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F
Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients | 0 | 0
|
| 38 | 7 | 96 2003 ONCOGENE 22(3):461-466
Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours | 0 | 0
|
| 39 | 1 | 18 2001 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98(26):14763-14765
Huebner K
Commentary - Tumor suppressors on 3p: A neoclassic quartet | 2 | 2
|
| 40 | 1 | 52 2002 GASTROENTEROLOGY 123(3):862-876
Jass JR; Whitehall VLJ; Young J; Leggett BA
Emerging concepts in colorectal neoplasia | 6 | 0
|
| 41 | 3 | 32 2002 CANCER RESEARCH 62(9):2715-2720
Ji L; Nishizaki M; Gao BN; Burbee D; Kondo M; Kamibayashi C; Xu K; Yen N; Atkinson EN; Fang BL; Lerman MI; Roth JA; Minna JD
Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo | 6 | 4
|
| 42 | 1 | 68 2002 NATURE REVIEWS GENETICS 3(6):415-428
Jones PA; Baylin SB
The fundamental role of epigenetic events in cancer | 60 | 7
|
| 43 | 2 | 45 2002 CURRENT BIOLOGY 12(4):253-265
Khokhlatchev A; Rabizadeh S; Xavier R; Nedwidek M; Chen T; Zhang XF; Seed B; Avruch J
Identification of a novel Ras-regulated proapoptotic pathway | 14 | 8
|
| 44 | 1 | 14 2001 ONCOGENE 20(43):6258-6262
Kondo M; Ji L; Kamibayashi C; Tomizawa Y; Randle D; Sekido Y; Yokota J; Kashuba V; Zabarovsky E; Kuzmin I; Lerman M; Roth J; Minna JD
Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells | 6 | 6
|
| 45 | 1 | 31 2002 CANCER RESEARCH 62(1):271-276
Konishi H; Nakagawa T; Harano T; Mizuno K; Saito H; Masuda A; Matsuda H; Osada H; Takahashi T
Identification of frequent G(2) checkpoint impairment and a homozygous deletion of 14-3-3 epsilon at 17p13.3 in small cell lung cancers | 5 | 2
|
| 46 | 5 | 100 2003 ONCOGENE 22(12):1892-1905
Konishi H; Sugiyama M; Mizuno K; Saito H; Yatabe Y; Takahashi T; Osada H; Takahashi T
Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer | 0 | 0
|
| 47 | 2 | 67 2002 MOLECULAR MEDICINE 8(8):419-436
Koutsami MK; Doussis-Anagnostopoulou I; Papavassiliou AG; Gorgoulis VG
Genetic and molecular coordinates of neuroendocrine lung tumors, with emphasis on small-cell lung carcinomas | 0 | 0
|
| 48 | 1 | 63 2002 JOURNAL OF PATHOLOGY 197(3):363-371
Krismann M; Muller KM; Jaworska M; Johnen G
Molecular cytogenetic differences between histological subtypes of malignant mesotheliomas: DNA cytometry and comparative genomic hybridization of 90 cases | 0 | 0
|
| 49 | 7 | 34 2002 CANCER RESEARCH 62(12):3498-3502
Kuzmin I; Gillespie JW; Protopopov A; Geil L; Dreijerink K; Yang YF; Vocke CD; Duh FM; Zabarovsky E; Minna JD; Rhim JS; Emmert-Buck MR; Linehan WM; Lerman MI
The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells | 4 | 4
|
| 50 | 1 | 39 2002 CLINICAL CANCER RESEARCH 8(1):131-137
Kwong J; Lo KW; To KF; Teo PML; Johnson PJ; Huang DP
Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma | 10 | 2
|
| 51 | 1 | 3 2001 CANCER RESEARCH 61(18):6688-6692
Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma | 17 | 17
|
| 52 | 1 | 8 2001 JOURNAL OF CLINICAL ONCOLOGY 19(18):74S-82S
Lippman SM; Spitz MR
Lung cancer chemoprevention: An integrated approach | 9 | 0
|
| 53 | 4 | 80 2002 ONCOGENE 21(44):6835-6840
Liu LM; Yoon JH; Dammann R; Pfeifer GP
Frequent hypermethylation of the RASSF1A gene in prostate cancer | 2 | 2
|
| 54 | 4 | 89 2002 SEMINARS IN CANCER BIOLOGY 12(6):451-462
Lo KW; Huang DP
Genetic and epigenetic changes in nasopharyngeal carcinoma | 0 | 0
|
| 55 | 6 | 38 2002 CANCER RESEARCH 62(20):5906-5911
Lusher ME; Lindsey JC; Latif F; Pearson ADJ; Ellison DW; Clifford SC
Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development | 1 | 1
|
| 56 | 1 | 1 2001 AMERICAN JOURNAL OF PATHOLOGY 159(1):119-130
Maitra A; Wistuba II; Washington C; Virmani AK; Ashfaq R; Milchgrub S; Gazdar AF; Minna JD
High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss | 21 | 6
|
| 57 | 1 | 83 2002 ONCOGENE 21(45):6960-6969
Mao L
Recent advances in the molecular diagnosis of lung cancer | 0 | 0
|
| 58 | 1 | 9 2001 JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY 54(5):300-306
Martinez A; Walker RA; Shaw JA; Dearing SJ; Maher ER; Latif F
Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features | 2 | 2
|
| 59 | 2 | 6 2001 CANCER RESEARCH 61(24):8659-8663
Maruyama R; Toyooka S; Toyooka KO; Harada K; Virmani AK; Zochbauer-Muller S; Farinas AJ; Vakar-Lopez F; Minna JD; Sagalowsky A; Czerniak B; Gazdar AF
Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features | 19 | 8
|
| 60 | 3 | 40 2002 CLINICAL CANCER RESEARCH 8(2):514-519
Maruyama R; Toyooka S; Toyooka KO; Virmani AK; Zochbauer-Muller S; Farinas AJ; Minna JD; McConnell J; Frenkel EP; Gazdar AF
Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features | 8 | 5
|
| 61 | 4 | 90 2003 CANCER LETTERS 190(2):199-211
Meireles SI; Carvalho AF; Hirata R; Montagnini AL; Martins WK; Runza FB; Stolf BS; Termini L; Neto CEM; Silva RLA; Soares FA; Neves EJ; Reis LFL
Differentially expressed genes in gastric tumors identified by cDNA array | 0 | 0
|
| 62 | 5 | 30 2002 CANCER JOURNAL 8():S41-S46
Minna JD; Fong K; Zochbauer-Muller S; Gazdar AF
Molecular pathogenesis of lung cancer and potential translational applications | 2 | 0
|
| 63 | 2 | 29 2002 CANCER CELL 1(1):49-52
Minna JD; Roth JA; Gazdar AF
Focus on lung cancer | 2 | 0
|
| 64 | 1 | 21 2002 AMERICAN JOURNAL OF MEDICAL GENETICS 115(3):183-188
Mitsuuchi Y; Testa JR
Cytogenetics and molecular genetics of lung cancer | 1 | 0
|
| 65 | 1 | 69 2002 ONCOGENE 21(15):2328-2333
Mizuno K; Osada H; Konishi H; Tatematsu Y; Yatabe Y; Mitsudomi T; Fujii Y; Takahashi T
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers | 3 | 0
|
| 66 | 1 | 5 2001 CANCER RESEARCH 61(19):7277-7281
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma | 21 | 17
|
| 67 | 1 | 55 2002 GENOMICS 79(3):344-348
Muneer S; Ramalingam V; Wyatt R; Schultz RA; Minna JD; Kamibayashi C
Genomic organization and mapping of the gene encoding the PP2A B56 gamma regulatory subunit | 0 | 0
|
| 68 | 3 | 86 2002 ONCOGENE 21(48):7421-7434
Osada H; Takahashi T
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer | 0 | 0
|
| 69 | 9 | 25 2002 BIOLOGICAL CHEMISTRY 383(6):907-914
Pfeifer GP; Yoon JH; Liu L; Tommasi S; Wilczynski SP; Dammann R
Methylation of the RASSF1A gene in human cancers | 0 | 0
|
| 70 | 1 | 47 2002 CURRENT OPINION IN ONCOLOGY 14(1):92-96
Polyak K
Molecular alterations in ductal carcinoma in situ of the breast | 1 | 0
|
| 71 | 3 | 42 2002 CLINICAL CANCER RESEARCH 8(11):3324-3331
Rathi A; Virmani AK; Schorge JO; Elias KJ; Maruyama R; Minna JD; Mok SC; Girard L; Fishman DA; Gazdar AF
Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women | 0 | 0
|
| 72 | 4 | 48 2002 CURRENT OPINION IN ONCOLOGY 14(2):171-179
Rosell R; Monzo M; O'Brate A; Taron M
Translational oncogenomics: toward rational therapeutic decision-making | 5 | 0
|
| 73 | 2 | 49 2002 CURRENT OPINION IN PULMONARY MEDICINE 8(4):265-269
Ross JA; Rosen GD
The molecular biology of lung cancer | 0 | 0
|
| 74 | 2 | 59 2002 JOURNAL OF BIOLOGICAL CHEMISTRY 277(39):36585-36591
Sarkar S; Roy BC; Hatano N; Aoyagi T; Gohji K; Kiyama R
A novel ankyrin repeat-containing gene (Kank) located at 9p24 is a growth suppressor of renal cell carcinoma | 0 | 0
|
| 75 | 1 | 77 2002 ONCOGENE 21(31):4822-4829
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines | 0 | 0
|
| 76 | 1 | 35 2002 CANCER RESEARCH 62(13):3698-3701
Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma | 4 | 3
|
| 77 | 8 | 99 2003 ONCOGENE 22(12):1866-1871
Schagdarsurengin U; Wilkens L; Steinemann D; Flemming P; Kreipe HH; Pfeifer GP; Schlegelberger B; Dammann R
Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma | 0 | 0
|
| 78 | 7 | 76 2002 ONCOGENE 21(29):4521-4529
Smith AJH; Xian J; Richardson M; Johnstone KA; Rabbitts PH
Cre-loxP chromosome engineering of a targeted deletion in the mouse corresponding to the 3p21.3 region of homozygous loss in human tumours | 1 | 1
|
| 79 | 8 | 91 2003 CANCER RESEARCH 63(7):1639-1643
Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DSB
Epigenetic inactivation of RAS Association Domain Family Protein 1 (RASSF1A) in malignant cutaneous melanoma | 0 | 0
|
| 80 | 2 | 41 2002 CLINICAL CANCER RESEARCH 8(7):2362-2368
Tomizawa Y; Kohno T; Kondo H; Otsuka A; Nishioka M; Niki T; Yamada T; Maeshima A; Yoshimura K; Saito R; Minna JD; Yokota J
Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma | 2 | 1
|
| 81 | 1 | 17 2001 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98(24):13954-13959
Tomizawa Y; Sekido Y; Kondo M; Gao BN; Yokota J; Roche J; Drabkin H; Lerman MI; Gazdar AF; Minna JD
Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B | 12 | 7
|
| 82 | 1 | 54 2002 GENES CHROMOSOMES & CANCER 34(4):349-353
Tomlinson IPM; Lambros MBK; Roylance RR
Loss of heterozygosity analysis: Practically and conceptually flawed? | 2 | 0
|
| 83 | 3 | 70 2002 ONCOGENE 21(17):2713-2720
Tommasi S; Dammann R; Jin SG; Zhang XF; Avruch J; Pfeifer GP
RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1 | 3 | 3
|
| 84 | 4 | 74 2002 ONCOGENE 21(27):4340-4344
Toyooka S; Carbone M; Toyooka K; Bocchetta M; Shivapurkar N; Minna JD; Gazdar AF
Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells | 2 | 1
|
| 85 | 2 | 93 2003 INTERNATIONAL JOURNAL OF CANCER 103(2):153-160
Toyooka S; Maruyama R; Toyooka KO; McLerran D; Feng ZD; Fukuyama Y; Virmani AK; Zochbauer-Muller S; Tsukuda K; Sugio K; Shimizu N; Shimizu K; Lee H; Chen CY; Fong KM; Gilcrease M; Roth JA; Minna JD; Gazdar AF
Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer | 0 | 0
|
| 86 | 2 | 2 2001 CANCER RESEARCH 61(15):5727-5730
Toyooka S; Pass HI; Shivapurkar N; Fukuyama Y; Maruyama R; Toyooka KO; Gilcrease M; Farinas A; Minna JD; Gazdar AF
Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma | 19 | 9
|
| 87 | 3 | 13 2001 MOLECULAR CANCER THERAPEUTICS 1(1):61-67
Toyooka S; Toyooka KO; Maruyama R; Virmani AK; Girard L; Miyajima K; Harada K; Ariyoshi Y; Takahashi T; Sugio K; Brambilla E; Gilcrease M; Minna JD; Gazdar AF
DNA methylation profiles of lung tumors | 11 | 5
|
| 88 | 4 | 78 2002 ONCOGENE 21(35):5450-5461
Tsou JA; Hagen JA; Carpenter CL; Laird-Offringa IA
DNA methylation analysis: a powerful new tool for lung cancer diagnosis | 0 | 0
|
| 89 | 7 | 72 2002 ONCOGENE 21(23):3792-3795
van Engeland M; Roemen GMJM; Brink M; Paachen MMM; Weijenberg MP; de Bruine AP; Arends JW; van den Brandt PA; de Goeij AFPM; Herman JG
K-ras mutations and RASSF1A promoter methylation in colorectal cancer | 3 | 0
|
| 90 | 1 | 7 2001 CLINICAL CANCER RESEARCH 7(7):1998-2004
Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas | 24 | 12
|
| 91 | 3 | 84 2002 ONCOGENE 21(47):7277-7282
Wagner KJ; Cooper WN; Grundy RG; Caldwell G; Jones C; Wadey RB; Morton D; Schofield PN; Reik W; Latif F; Maher ER
Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer | 2 | 1
|
| 92 | 1 | 19 2001 SEMINARS IN ONCOLOGY 28(2):3-13
Wistuba II; Gazdar AF; Minna JD
Molecular genetics of small cell lung carcinoma | 15 | 5
|
| 93 | 2 | 85 2002 ONCOGENE 21(48):7298-7306
Wistuba II; Mao L; Gazdar AF
Smoking molecular damage in bronchial epithelium | 1 | 0
|
| 94 | 3 | 26 2002 BRITISH JOURNAL OF CANCER 87(4):432-440
Wistube II; Maitra A; Carrasco R; Tang M; Troncoso P; Minna JD; Gazdar AF
High resolution chromosome 3p, 8p, 9q and 22q allelotyping analysis in the pathogenesis of gallbladder carcinoma | 0 | 0
|
| 95 | 2 | 61 2002 JOURNAL OF HEPATOLOGY 37(5):633-639
Wong N; Li L; Tsang K; Lai PBS; To KF; Johnson PJ
Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma | 0 | 0
|
| 96 | 3 | 62 2002 JOURNAL OF HUMAN GENETICS 47(9):453-459
Yang QF; Yoshimura G; Mori I; Sakurai T; Kakudo K
Chromosome 3p and breast cancer | 0 | 0
|
| 97 | 1 | 88 2002 ONCOLOGY REPORTS 9(6):1329-1333
Yang QF; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
BRCA1 in non-inherited breast carcinomas (Review) | 0 | 0
|
| 98 | 15 | 82 2002 ONCOGENE 21(45):6915-6935
Zabarovsky ER; Lerman MI; Minna JD
Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers | 2 | 0
|
| 99 | 6 | 66 2002 MOLECULAR CARCINOGENESIS 35(2):85-92
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B-1-DNA adduct levels in human hepatocellular carcinoma | 1 | 0
|
| 100 | 2 | 24 2002 ANNUAL REVIEW OF PHYSIOLOGY 64():681-708
Zochbauer-Muller S; Gazdar AF; Minna JD
Molecular pathogenesis of lung cancer | 12 | 0
|